Trending NewsTrending NewsNYSE:DVA DaVita (DVA) Stock Price, News & Analysis $129.55 +1.86 (+1.46%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$129.54 -0.01 (-0.01%) As of 08/8/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About DaVita Stock (NYSE:DVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get DaVita alerts:Sign Up Key Stats Today's Range$127.32▼$130.5150-Day Range$127.61▼$151.4752-Week Range$126.07▼$179.60Volume949,567 shsAverage Volume883,366 shsMarket Capitalization$9.26 billionP/E Ratio12.74Dividend YieldN/APrice Target$164.00Consensus RatingHold Company Overview DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Read More DaVita Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks96th Percentile Overall ScoreDVA MarketRank™: DaVita scored higher than 96% of companies evaluated by MarketBeat, and ranked 45th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingDaVita has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageDaVita has only been the subject of 2 research reports in the past 90 days.Read more about DaVita's stock forecast and price target. Earnings and Valuation4.4 / 5Proj. Earnings Growth18.12% Earnings GrowthEarnings for DaVita are expected to grow by 18.12% in the coming year, from $10.76 to $12.71 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of DaVita is 12.74, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.88.Price to Earnings Ratio vs. SectorThe P/E ratio of DaVita is 12.74, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.76.Price to Earnings Growth RatioDaVita has a PEG Ratio of 0.88. PEG Ratios below 1 indicate that a company could be undervalued. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted8.17% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in DaVita has recently decreased by 3.61%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldDaVita does not currently pay a dividend.Dividend GrowthDaVita does not have a long track record of dividend growth. Sustainability and ESG4.5 / 5Environmental Score-1.06 Percentage of Shares Shorted8.17% of the float of DaVita has been sold short.Short Interest Ratio / Days to CoverDaVita has a short interest ratio ("days to cover") of 7.3.Change versus previous monthShort interest in DaVita has recently decreased by 3.61%, indicating that investor sentiment is improving. News and Social Media2.6 / 5News Sentiment0.60 News SentimentDaVita has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.38 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 34 news articles for DaVita this week, compared to 12 articles on an average week.Search InterestOnly 4 people have searched for DVA on MarketBeat in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, DaVita insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $352,650.00 in company stock.Percentage Held by InsidersOnly 2.00% of the stock of DaVita is held by insiders.Percentage Held by Institutions90.12% of the stock of DaVita is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about DaVita's insider trading history. Receive DVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for DaVita and its competitors with MarketBeat's FREE daily newsletter. Email Address DVA Stock News HeadlinesJames O. Hearty Sells 2,351 Shares of DaVita Inc. (NYSE:DVA) StockJuly 25, 2025 | insidertrades.comBarclays Sticks to Its Hold Rating for DaVita (DVA)August 9 at 2:45 AM | theglobeandmail.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.August 9 at 2:00 AM | Brownstone Research (Ad)TD Cowen Remains a Hold on DaVita (DVA)August 8 at 5:42 AM | theglobeandmail.comDaVita Healthcare’s Resilient Earnings Call Amid ChallengesAugust 8 at 5:42 AM | theglobeandmail.comDaVita Healthcare’s Resilient Earnings Call Amid ChallengesAugust 8 at 5:42 AM | theglobeandmail.comDaVita Inc. (NYSE:DVA) Q2 2025 Earnings Call TranscriptAugust 8 at 5:42 AM | msn.comDaVita Inc (DVA) Q2 2025 Earnings Call Highlights: Navigating Challenges with Resilience and ...August 7 at 5:48 AM | finance.yahoo.comSee More Headlines DVA Stock Analysis - Frequently Asked Questions How have DVA shares performed this year? DaVita's stock was trading at $149.55 at the beginning of the year. Since then, DVA shares have decreased by 13.4% and is now trading at $129.5520. How were DaVita's earnings last quarter? DaVita Inc. (NYSE:DVA) issued its quarterly earnings data on Tuesday, August, 5th. The company reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. The business's revenue for the quarter was up 6.1% on a year-over-year basis. Read the conference call transcript. Does DaVita have any subsidiaries? The following companies are subsidiaries of DaVita: Northwest Physicians Network, Purity Dialysis, Family Health Care of Central Florida, Healthcare Partners, Gambro Healthcare, Aberdeen Dialysis LLC, Accountable Kidney Care LLC, and others. Who are DaVita's major shareholders? Top institutional investors of DaVita include Geode Capital Management LLC (1.55%), KBC Group NV (0.52%), Bank of New York Mellon Corp (0.47%) and Allianz Asset Management GmbH (0.46%). Insiders that own company stock include Javier Rodriguez, Michael David Staffieri, Joel Ackerman, Kathleen Alyce Waters, James O Hearty, Charles Berg, John M Nehra, Phyllis R Yale and Barbara J Desoer. View institutional ownership trends. How do I buy shares of DaVita? Shares of DVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of DaVita own? Based on aggregate information from My MarketBeat watchlists, some other companies that DaVita investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), TotalEnergies (TTE) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/05/2025Today8/09/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED - OUTP/HM CRE Sub-IndustryHealth Care Services Current SymbolNYSE:DVA CIK927066 Webwww.davita.com Phone(720) 631-2100Fax302-636-5454Employees76,000Year Founded1999Price Target and Rating Average Price Target for DaVita$164.00 High Price Target$184.00 Low Price Target$148.00 Potential Upside/Downside+26.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)$10.17 Trailing P/E Ratio12.74 Forward P/E Ratio12.04 P/E Growth0.88Net Income$936.34 million Net Margins6.35% Pretax Margin10.96% Return on Equity369.39% Return on Assets4.62% Debt Debt-to-Equity Ratio23.18 Current Ratio1.39 Quick Ratio1.20 Sales & Book Value Annual Sales$12.82 billion Price / Sales0.72 Cash Flow$19.42 per share Price / Cash Flow6.67 Book Value($1.51) per share Price / Book-85.80Miscellaneous Outstanding Shares71,500,000Free Float70,070,000Market Cap$9.26 billion OptionableOptionable Beta1.09 Social Links These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSE:DVA) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DaVita Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DaVita With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.